07.13.2021
Prevent & Delay
$354,073.00
48 months
Longitudinal study of the GLUcagon REsponse to hypoglycemia in children and adolescents with new-onset type 1 DIAbetes (GLUREDIA study): characteristics and predictive biomarkers
Funds support research into understanding alpha cell dysfunction and hypoglycemia profiles in new-onset cases of type 1 diabetes